SUNPHARMA
₹1779.72.3 (0.13%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Net Sales have consistently increased over the past four quarters, indicating strong market demand for SUNPHARMA's products.
- Operating profit margins have improved, peaking at 24.33% in the latest quarter, reflecting efficient cost management.
- The latest quarter's net profit of ₹2912.98 Crore demonstrates strong financial health amid rising sales and profits compared to earlier quarters.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12,380.70 | 11,982.90 | 12,652.80 | 13,291.40 | 13,675.50 | 12,958.80 | 13,851.40 | 14,478.30 | |
| Expenses | 9,685.30 | 9,671.68 | 9,761.80 | 10,175.60 | 10,348.50 | 10,246.90 | 10,554.10 | 11,211.10 | |
| Operating Profit | 2,695.40 | 2,311.22 | 2,891 | 3,115.80 | 3,327 | 2,711.90 | 3,297.30 | 3,267.20 | |
| Other Income | 374.76 | 605.94 | 532.55 | 482.09 | 465.62 | 904.11 | 693.50 | 900.39 | |
| Interest | 34.73 | 73.57 | 61.54 | 69.17 | 51.51 | 49.14 | 74.80 | 99.86 | |
| Depreciation | 622.14 | 650.36 | 655.13 | 625.91 | 630.56 | 663.79 | 700.55 | 729.50 | |
| Profit Before Tax | 2,992.86 | 2,807.67 | 3,412.76 | 3,604.54 | 3,471.84 | 3,247.64 | 3,163.02 | 4,155.47 | |
| Tax | 432.32 | 148.93 | 552.25 | 567.21 | 558.86 | 1,093.71 | 870.15 | 1,030.52 | |
| Net Profit | 2,560.54 | 2,658.74 | 2,860.51 | 3,037.33 | 2,912.98 | 2,153.93 | 2,292.87 | 3,124.95 | |
| EPS in Rs | 10.50 | 11.10 | 11.80 | 12.70 | 12.10 | 9 | 9.50 | 13 |